Viagra May Reduce Colorectal Cancer Risk

 

Among all the causes to cancer death, colorectal cancer ranks the third. However, a research team has lately released an important finding that can potentially reduces the risk of colorectal cancer significantly. The researchers applied a small, daily dose of Viagra in an animal model and the result is promising.

According to the researchers from Georgia Cancer Center and Department of Biochemistry and Molecular Biology, Viagra cut in half the formation of polyps, an abnormal and often asymptomatic clump of cells on the lining of the intestines that may become cancer.

Next steps should include a clinical trial for the drug in patients considered at high risk of colorectal cancer, such as those with a strong family history, multiple previous polyps or chronic intestinal inflammation like colitis.

Viagra has been used safely for years in a wide range of doses and age groups, from premature infants with pulmonary hypertension to the elderly with erectile dysfunction.

HTQ will follow up on the progress of the clinical trials.

 

Leave a Reply